- Home
- PRME vs WDAY Comparison
PRME vs WDAY Comparison
Compare PRME & WDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- WDAY
- Stock Information
- Founded
- PRME 2019
- WDAY 2005
- Country
- PRME United States
- WDAY United States
- Employees
- PRME N/A
- WDAY N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- WDAY EDP Services
- Sector
- PRME Health Care
- WDAY Technology
- Exchange
- PRME Nasdaq
- WDAY Nasdaq
- Market Cap
- PRME 191.7M
- WDAY N/A
- IPO Year
- PRME 2022
- WDAY 2012
- Fundamental
- Price
- PRME $3.15
- WDAY $241.76
- Analyst Decision
- PRME Buy
- WDAY Buy
- Analyst Count
- PRME 6
- WDAY 27
- Target Price
- PRME $9.38
- WDAY $301.85
- AVG Volume (30 Days)
- PRME 3.6M
- WDAY 2.0M
- Earning Date
- PRME 08-04-2025
- WDAY 08-21-2025
- Dividend Yield
- PRME N/A
- WDAY N/A
- EPS Growth
- PRME N/A
- WDAY N/A
- EPS
- PRME N/A
- WDAY 1.81
- Revenue
- PRME $3,846,000.00
- WDAY $8,696,000,000.00
- Revenue This Year
- PRME $104.12
- WDAY $14.87
- Revenue Next Year
- PRME $196.78
- WDAY $13.03
- P/E Ratio
- PRME N/A
- WDAY $133.48
- Revenue Growth
- PRME 550.76
- WDAY 14.95
- 52 Week Low
- PRME $1.11
- WDAY $199.81
- 52 Week High
- PRME $6.75
- WDAY $294.00
- Technical
- Relative Strength Index (RSI)
- PRME 80.66
- WDAY 47.69
- Support Level
- PRME $2.28
- WDAY $233.91
- Resistance Level
- PRME $3.34
- WDAY $241.00
- Average True Range (ATR)
- PRME 0.32
- WDAY 4.77
- MACD
- PRME 0.13
- WDAY 0.10
- Stochastic Oscillator
- PRME 95.36
- WDAY 59.66
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.